01 1Ambiopharm, Inc.
02 1Apicore Pharmaceuticals Private Limited
03 1Azico Biophore India Private Limited
04 1Chinese Peptide Company
05 1GP PHARM SA
06 1Hemmo Pharmaceuticals Pvt. Ltd
07 5Piramal Pharma Limited
01 1CETRORELIX ACETATE
02 1Cetrorelix
03 6Cetrorelix Powder (Synthetic)
04 2Cetrorelix acetate
05 1cetrorelix acetate
01 1China
02 2India
03 1Spain
04 7U.S.A
NDC Package Code : 41524-0013
Start Marketing Date : 2021-12-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-326
Start Marketing Date : 2021-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 43963-003
Start Marketing Date : 2024-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69112-103
Start Marketing Date : 2022-08-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (0.25mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 41701-011
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1.2g/1.2g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-011
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.1g/.1g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-011
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.45g/.45g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-011
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15g/15g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-011
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (16.5g/16.5g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-011
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Cetrorelix Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cetrorelix Acetate, including repackagers and relabelers. The FDA regulates Cetrorelix Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cetrorelix Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cetrorelix Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cetrorelix Acetate supplier is an individual or a company that provides Cetrorelix Acetate active pharmaceutical ingredient (API) or Cetrorelix Acetate finished formulations upon request. The Cetrorelix Acetate suppliers may include Cetrorelix Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Cetrorelix Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cetrorelix Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cetrorelix Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cetrorelix Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cetrorelix Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cetrorelix Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cetrorelix Acetate suppliers with NDC on PharmaCompass.
We have 6 companies offering Cetrorelix Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
